Clinical trial
Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial…
NCT00114452 · Mesoblast, Inc., Industry · Completed
Key facts
| NCT number | NCT00114452 |
|---|---|
| Title | Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction |
| Official title | A Phase 1 Randomized, Double-blind, Placebo-controlled, Dose Escalation, Multicenter Study to Determine the Safety of Intravenous Ex-vivo Cultured Adult Human Mesenchymal Stem Cells (Provacel) Following Acute Myocardial Infarction |
| Lead sponsor | Mesoblast, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Biological |
| Interventions | Provacel, Placebo |
| Enrollment | 60 |
| Start date | Mar 22, 2005 |
| Primary completion | Oct 4, 2006 |
| Completion | Apr 24, 2008 |
| First posted | Jun 15, 2005 |
| Last update posted | Mar 10, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: